Investor
welcome to our
Investor Relation portal
Welcome to our Investor Relations Portal! Here you can learn more about Protea’s game-changing bioanalytical technology, our management team, board of directors, science advisory board, as well as access SEC filings and other information resources.
Recent Releases
- Protea Announces First Quarter 2016 Results – Revenue increases 22% over Q1 2015 | PDF Version
May 16, 2016 - Protea announces license agreement with Yale | PDF Version
Apr 25, 2016 - New Potential Lung Cancer Biomarkers Identified | PDF Version
Apr 19, 2016 - Protea Announces 2015 Year End Results | PDF Version
Mar 16, 2016
BIO CEO & Investor Conference 2016 – Protea Presentation
Upcoming Meetings
Shareholder Report – Jan 2015
